Food and Staples Retailing Drug Retail

More

  • NEW DELHI/ MUMBAI, Oct 9- As many as 850,000 small chemist shops in India will shut for a day next week to protest against a burgeoning online pharmacy industry that is attracting big money backers. Healthcare provider Apollo Hospitals Enterprise Ltd plans to start online drug sales in India, while Zigy, and Sequoia Capital- backed 1 mg already have e-pharmacies to...

  • NEW DELHI/ MUMBAI, Oct 9- As many as 850,000 small chemist shops in India will shut for a day next week to protest against a burgeoning online pharmacy industry that is attracting big money backers. Healthcare provider Apollo Hospitals Enterprise Ltd plans to start online drug sales in India, while Zigy, and Sequoia Capital- backed 1 mg already have e-pharmacies to...

  • Cure for blindness? Monday, 5 Oct 2015 | 3:17 PM ET
    Cure for blindness?

    Spark Therapeutics is working on an experimental gene therapy for an inherited eye disorder, and it has the potential to be the first gene therapy on the market in the U.S.

  • Spark Therapeutics' eying FDA approval Monday, 5 Oct 2015 | 8:00 AM ET
    Spark Therapeutics' eying FDA approval

    Spark Therapeutics' gene therapy for rare, inherited forms of blindness met the goals of a late-stage study.

  • Promising results on arthritis drug Friday, 25 Sep 2015 | 8:00 AM ET
    Promising results on arthritis drug

    AbbVie said its experimental drug improved symptoms of rheumatoid arthritis in patients in two mid-stage studies.

  • Biotech CEO speaks out after Turing price hike Wednesday, 23 Sep 2015 | 8:20 AM ET
    Biotech CEO speaks out after Turing price hike

    CNBC's Meg Tirrell speaks to Alnylam Pharmaceuticals CEO John Maraganore, about drug pricing in the U.S.

  • Hillary Clinton outlines drug cost plan Tuesday, 22 Sep 2015 | 3:55 PM ET
    Hillary Clinton outlines prescription cost plan

    Democratic presidential candidate Hillary Clinton unveils her plan to lower prescription drug costs.

  • Hillary Clinton: I want to put an end to profiteering

    Democratic presidential candidate Hillary Clinton addresses innovation in the pharmaceutical and biotech industries, and unveils her plan to lower prescription drug costs.

  • Your money or your life? Tuesday, 22 Sep 2015 | 1:46 PM ET
    Your money or your life?

    Dr. Peter Bach, MD of Memorial Sloan Kettering Cancer Center, weighs in on Turing Pharmaceuticals' decision to increase a single dose of Daraprim from $13.50 to $750.

  • Clinton lays out drug plan Tuesday, 22 Sep 2015 | 10:20 AM ET
    Democratic Presidential candidate Hillary Clinton speaks during a community forum on substance abuse September 17, 2015 in Laconia, New Hampshire.

    CNBC's Meg Tirrell reports on Hillary Clinton's drug plan, one day after she criticized drug price gouging.

  • High costs for drug development Monday, 21 Sep 2015 | 1:38 PM ET
    High costs for drug development

    Hillary Clinton is criticizing drug price gouging. Steve Case, Revolution Chairman and CEO, shares his take.

  • Drug price outrage Monday, 21 Sep 2015 | 12:34 PM ET
    Drug price outrage

    Hillary Clinton is criticizing drug price gouging, after news a drug company hiked the price of one of its drugs by 5,000 percent overnight, with CNBC's Meg Tirrell.

  • *Forecasts profit of $0.12- $0.19/ shr. Sept 17- Drugstore chain operator Rite Aid Corp cut its full-year forecasts for total earnings and drugstore sales, citing lower pharmacy reimbursements and expenses related to its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Rite Aid shares fell nearly 9 percent in morning trading on Thursday.

  • Sept 17- Drugstore chain operator Rite Aid Corp cut its full-year forecast for drugstore sales and total earnings, citing "recent sales trends" and expenses related to its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Rite Aid cut its drugstore sales forecast for the year ending February to $26.7 billion- $27.0 billion from $26.9 billion-...

  • Sept 17- Drugstore chain operator Rite Aid Corp reported a 17.5 percent rise in quarterly revenue, helped by its $2 billion acquisition of pharmacy benefit manager EnvisionRx. Net income fell to $21.5 million, or 2 cents per share, in the second quarter ended Aug. 29, from $127.8 million, or 13 cents per share, a year earlier. Revenue rose to $7.66 billion from $6.52...

  • Heart of California's marijuana industry Wednesday, 16 Sep 2015 | 11:05 AM ET
    Heart of California's marijuana industry

    CNBC's Jane Wells reports from Arcata, California, where the city council wants to build the country's first marijuana innovation zone.

  • Lifesaving blood pressure study Friday, 11 Sep 2015 | 1:09 PM ET
    Lifesaving blood pressure study

    A new government study on blood pressure found potentially lifesaving results, reports CNBC's Meg Tirrell.

  • A setback for GSK Wednesday, 9 Sep 2015 | 10:00 AM ET
    A setback for GSK

    Disappointing clinical results for GSK-Theravance respiratory treatment.

  • CHICAGO, Sept 3- CVS Health Corp said on Thursday its decision to stop selling tobacco products last year led to a 1 percent decrease in cigarette sales in some states where the drugstore chain has a sizeable presence. The September 2014 decision hurt sales, with general merchandise revenue at CVS pharmacies open at least a year falling 7.8 percent in the second...

  • Amgen approved for pricey new drug Friday, 28 Aug 2015 | 6:00 AM ET
    Amgen approved for pricey new drug

    Amgen wins FDA approval for cholesterol-lowering drug Repatha.